Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial

Authors:: Neda Rezvan; Ashraf Moini; Sattar Gorgani-Firuzjaee; Mohammad Javad Hosseinzadeh-Attar

Reference:: Cell Journal; 2018; 19; 627-633

DOI:: 10.22074/CELLJ.2018.4577

See Abstract

Key Words:: Clinical study; randomization; double blind; placebo controlled; parallel-group; polycystic ovarian syndrome; quercetin; adiponectin receptor; AMPK

Back to index